Crossmark

A scientific journey from discovery to validation of efficacy in cancer patients: HAMLET and alpha1-oleate

Crossref DOI link: https://doi.org/10.1080/23723556.2021.1974278

Published Online: 2021-09-30

Published Print: 2021-09-03

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Ho, James C.S.

Ambite, Ines

Mok, K. H.

Babjuk, Marek

Svanborg, Catharina
Funding

Funding for this research was provided by:

Cancerfonden

Horizon 2020 (954360)

HAMLET Pharma

Vetenskapsrådet
License Information

License valid from 2021-09-03
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=kmco20

Publication History

Received: 2021-08-12

Revised: 2021-08-20

Accepted: 2021-08-25

Published: 2021-09-30